• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Solvay Invests in Suanfarma’s Vanillin Production

    GNC Adds Products from The Honest Company, Hers, and Womaness

    NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program

    Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Solvay Invests in Suanfarma’s Vanillin Production

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

    Leaven Essential to Launch Branded Botanical Extracts to Global Markets

    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Solvay Invests in Suanfarma’s Vanillin Production

    GNC Adds Products from The Honest Company, Hers, and Womaness

    Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

    Leaven Essential to Launch Branded Botanical Extracts to Global Markets
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    GNC Adds Products from The Honest Company, Hers, and Womaness

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

    Red Seaweed Digestive Supplement for Cattle Could Reduce Enteric Methane Emissions by 80%

    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults

    Vitamin Angels’ Mother’s Day Donation Campaign Raises Awareness for Maternal and Child Nutrition
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    Aiya America, Inc. (Aiya Matcha)

    Xsto Solutions

    Ecuadorian Rainforest

    Botanic Healthcare LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Nutrition21, LLC

    Aiya America, Inc. (Aiya Matcha)

    Xsto Solutions

    Ecuadorian Rainforest

    Botanic Healthcare LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    American Botanical Council: Schedule 1 Status of Cannabis ‘Outdated and Inappropriate’

    Non-profit recommends action to enable access of cannabis and its components for medicinal investigations.

    American Botanical Council: Schedule 1 Status of Cannabis ‘Outdated and Inappropriate’
    Related CONTENT
    • Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    • How Blockchain Can Improve Transparency in the Dietary Supplement Industry
    • Beyond CBD: Cannabis Compounds Warrant Recognition and More Research
    • Lead the Hemp and CBD Market with Science
    • Cannabis Sales Predicted to Surpass $61 Billion Globally by 2026
    04.27.18
    The non-profit American Botanical Council (ABC) recently submitted comments to the U.S. Food and Drug Administration (FDA) noting “that more clinical and other research into the medicinal properties of cannabis is warranted, and that the Schedule 1 status of cannabis is one of the most significant impediments to carry out such research.”
     
    ABC’s submission was in response to the FDA’s request for “comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use” of five substances: cannabis plant and resin; extracts and tinctures of cannabis; delta-9-tetrahydrocannabinol (THC); stereoisomers of THC; and cannabidiol (CBD).

    The U.S. Department of Health and Human Services (HHS) will take the public comments into consideration as the HHS prepares its response to a request for information from the World Health Organization (WHO). According to the FDA, the WHO “will use this information to consider whether to recommend that certain international restrictions be placed on these drugs.”

    In its comments, ABC emphasized that cannabis’s Schedule I status under the Controlled Substances Act (CSA) of 1970 is outdated and inappropriate. A Schedule 1 drug or substance is defined as having (A) “a high potential for abuse”; (B) “no currently accepted medical use in treatment in the United States”; and (C) “a lack of accepted safety for use … under medical supervision.”

    “In 1970, when the Controlled Substances Act was enacted, reliable information on the medical value of cannabis was relatively scarce,” the non-profit noted in its comments. “This has changed over the past years, where a number of clinical studies have been carried out to evaluate cannabis, and cannabis isolates, for a variety of conditions and ailments.”

    In the comments sent to the FDA, ABC provided short summaries with evidence of the benefits of cannabis, and cannabis fractions enriched in CBD, or THC and CBD, as therapeutic agents in the treatment of pain, multiple sclerosis, and epilepsy. The data included are based on a literature review, including a number of systematic reviews and meta-analyses published between 2015 and 2018. The publications substantiate that cannabis preparations have significant medical benefits.

    ABC concluded: “Based on the promising results from the human studies on cannabis, the current hurdles to investigate cannabis, cannabis extracts, and purified fractions obtained from cannabis, as promising ingredients for a number of medical issues do not seem appropriate in view of the potential benefits that this plant might provide. Therefore, [ABC] recommends that cannabis be removed from Schedule I from the Controlled Substances Act and that other appropriate actions are undertaken to enable more appropriate access of cannabis and its components for medicinal investigations.”

    The FDA notice explains that HHS will simply provide an evaluation of the five substances, not a recommendation for their scheduling, to the WHO, which will conduct a “pre-review” of the evidence during a special session on cannabis and cannabis-related substances at the 40th meeting of the Expert Committee on Drug Dependence, which will be held in Geneva, Switzerland, from June 4-8, 2018.

    ABC’s comments were written by ABC Chief Science Officer Stefan Gafner, PhD. A copy of ABC’s comments to the FDA is available here.
    Related Searches
    • Health
    • Research
    • fda
    • Botanical
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    Suggested For You
    Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    How Blockchain Can Improve Transparency in the Dietary Supplement Industry How Blockchain Can Improve Transparency in the Dietary Supplement Industry
    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research Beyond CBD: Cannabis Compounds Warrant Recognition and More Research
    Single-Center Study Evaluates Effects of Novel Retinol and Cannabidiol Combination Topical on Facial Skin Single-Center Study Evaluates Effects of Novel Retinol and Cannabidiol Combination Topical on Facial Skin
    Hemp and CBD Updates: Industry Still in the Weeds Hemp and CBD Updates: Industry Still in the Weeds
    Cannabis Sales Predicted to Surpass $61 Billion Globally by 2026 Cannabis Sales Predicted to Surpass $61 Billion Globally by 2026
    Keeping Score: CBD in Sports Keeping Score: CBD in Sports
    Brand Obsession Has Entered the CBD Category Brand Obsession Has Entered the CBD Category
    Lead the Hemp and CBD Market with Science Lead the Hemp and CBD Market with Science
    BESO Wellness Taps Tradition to Offer Modern Cannabis Formulations BESO Wellness Taps Tradition to Offer Modern Cannabis Formulations
    CBD and CBN Sleep Products Hit the High Notes CBD and CBN Sleep Products Hit the High Notes
    CBD in Topical Formulations CBD in Topical Formulations
    Open Book Extracts Announces Completion of Study on Rare Cannabinoids for Pain Open Book Extracts Announces Completion of Study on Rare Cannabinoids for Pain
    Hello Again Brand Sets to Lift Women’s Health with Cannabis Product Line Hello Again Brand Sets to Lift Women’s Health with Cannabis Product Line
    Verdant Oasis’ Whole-Plant Hemp Extract Self-Affirmed GRAS Verdant Oasis’ Whole-Plant Hemp Extract Self-Affirmed GRAS

    Related Content

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Natural/Organic | Regulations | World Markets
      Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing

      Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing

      Marc Ross discusses how companies getting in front of ESG are well-positioned to win investors, talent, and customers.
      By Sheldon Baker, CEO Baker Dillon Group LLC 05.03.22

    • Dietary Supplements | Healthcare Trends | Quality & Safety | World Markets
      How Blockchain Can Improve Transparency in the Dietary Supplement Industry

      How Blockchain Can Improve Transparency in the Dietary Supplement Industry

      Technology that can track a sequence of transactions helps build trust among stakeholders along the supply chain, as well as between consumers and brands.
      By Robert Galaza, CEO, TruTrace Technologies 04.14.22

    • Herbs & Botanicals | Research
      Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

      Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

      With growing consumer usage, scientists must continue exploring the many constituents of cannabis, their interactions, and potential health effects.
      By Sean Moloughney, Editor 04.14.22


    • Dietary Supplements | Herbs & Botanicals | Regulations
      Lead the Hemp and CBD Market with Science

      Lead the Hemp and CBD Market with Science

      CBD has been an entry point—a starting block. The runway ahead is vast.
      By Sean Moloughney, Editor 04.07.22

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals
      Cannabis Sales Predicted to Surpass $61 Billion Globally by 2026

      Cannabis Sales Predicted to Surpass $61 Billion Globally by 2026

      While sales softened for most legal cannabis markets in the second half of 2021, new markets are driving growth, according to BDSA report.
      04.07.22

      Breaking News
      • Solvay Invests in Suanfarma’s Vanillin Production
      • GNC Adds Products from The Honest Company, Hers, and Womaness
      • NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program
      • Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark
      • Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Solvay Invests in Suanfarma’s Vanillin Production
      GNC Adds Products from The Honest Company, Hers, and Womaness
      NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program
      Coatings World

      Latest Breaking News From Coatings World

      PPG Launches HOMAX TEX>>PRO Texture System by PPG
      New Digital Solution from Interpon Helps Customers Bring Colors to Life
      What Are You Reading?
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Texas Medical Center Partners with Enterprise Ireland
      MMT Acquires Medical Production Technology Europe
      Avanos Recalls Cortrak*2 Over Potential Enteral Tube Misplacement
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Catalent Introduces UpTempo Virtuoso Platform
      Elicio Therapeutics Enters Clinical Supply Agreement with Regeneron
      Reaction Biology Expands Executive Leadership Team
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      A Look at Machine Gun Kelly's $30K Diamond Mani
      Doja Cat Rocks Glam Makeup & Nails at the Billboard Music Awards
      Maggie Q Launches Beauty Supplement
      Happi

      Latest Breaking News From Happi

      Dr. Squatch Launches Black Hole Bar Soap in Light of Recently-Revealed Black Hole in Milky Way
      Nautica Introduces Nautica Oceans Pacific Coast Collection
      Thread Beauty Launches Vegan Lip Gloss Collection
      Ink World

      Latest Breaking News From Ink World

      INX to Highlight Color Perfection Program, INX University at GulfCan
      Kornit Hosts Kornit Fashion Week London 2022
      Zeller+Gmelin Launches UV-Curable and Water-Based Inkjet Inks
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Schreiner ProTech introduces new PCS solution for electric vehicle charging
      FTA and FFTA announce 2022-2023 board updates
      Bar Graphic and J&J Converting open US demo center
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Essity Wins Innovation Award at Interclean
      Weekly Recap: Ontex Confirms Possibility of Attindas Deal, Purell Launches New Wipes & More
      TSG Finishing Starts Modernization Project
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Denise Pedulla Appointed as Chief Legal Officer at Conformis
      ODT's Most-Read Stories This Week—May 14
      Steven Haddad Joins Extremity Medical as Chief Clinical Officer
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Google Cloud, Saule Technologies and Columbus Energy Begin Strategic Cooperation
      JDI Develops eLEAP, World’s First Maskless Deposition + Lithographic OLED
      Toppan Develops Temperature Logger Label for Long-Distance Transportation

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login